Published in J Biol Chem on August 05, 2004
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci (2007) 1.64
LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics (2010) 1.37
Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem (2007) 1.19
The SALM family of adhesion-like molecules forms heteromeric and homomeric complexes. J Biol Chem (2008) 0.92
Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem (2012) 0.88
Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury. J Neurosci (2015) 0.87
Functional delay of myelination of auditory delay lines in the nucleus laminaris of the barn owl. Dev Neurobiol (2007) 0.86
Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J (2011) 0.85
Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice. J Neurosci (2015) 0.82
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor. Chin J Traumatol (2016) 0.75
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol (2006) 4.38
Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25
Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 4.23
Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science (2005) 4.15
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev (2010) 3.99
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science (2002) 3.50
The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron (2003) 3.50
Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron (2010) 3.44
Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci (2010) 3.36
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron (2009) 3.34
Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 3.33
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther (2010) 3.26
Involvement of actin-related proteins in ATP-dependent chromatin remodeling. Mol Cell (2003) 2.99
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci (2012) 2.92
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov (2013) 2.88
Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci (2003) 2.76
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron (2004) 2.76
Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci (2004) 2.67
A new role for Nogo as a regulator of vascular remodeling. Nat Med (2004) 2.63
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci (2006) 2.28
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med (2007) 2.17
RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol (2004) 2.14
Multiple actions of systemic artemin in experimental neuropathy. Nat Med (2003) 2.12
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci (2003) 2.11
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med (2011) 2.08
Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci (2002) 2.01
Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci (2002) 1.96
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci (2007) 1.88
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87
MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci (2010) 1.86
Primary cilia of human endothelial cells disassemble under laminar shear stress. J Cell Biol (2004) 1.86
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol (2009) 1.86
Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules. Cell (2003) 1.83
Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J (2003) 1.78
The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci (2006) 1.77
Neogenin mediates the action of repulsive guidance molecule. Nat Cell Biol (2004) 1.77
Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci (2008) 1.66
Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci (2010) 1.66
Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci (2007) 1.64
The reticulons: a family of proteins with diverse functions. Genome Biol (2007) 1.62
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A (2007) 1.58
Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci (2002) 1.55
Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci (2003) 1.52
Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc (2007) 1.48
Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury. Nat Neurosci (2008) 1.47
Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol (2006) 1.44
The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol (2007) 1.43
Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci (2005) 1.43
Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res (2004) 1.42
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A (2010) 1.42
Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci U S A (2006) 1.39
Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure (2008) 1.39
ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist (2007) 1.38
The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci (2008) 1.38
Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ (2009) 1.37
LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci (2009) 1.32
Structural bases for CRMP function in plexin-dependent semaphorin3A signaling. EMBO J (2003) 1.29
Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke (2010) 1.25
Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov (2003) 1.25
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J Neurosci (2006) 1.24
Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci (2006) 1.24
Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci (2009) 1.22
Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush. J Neurosci (2009) 1.20
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
Two flagellar genes, AGG2 and AGG3, mediate orientation to light in Chlamydomonas. Curr Biol (2006) 1.18
Anatomical plasticity of adult brain is titrated by Nogo Receptor 1. Neuron (2013) 1.18
Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci (2006) 1.16
Response to correspondence: Kim et al., "axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron (2007) 1.15
Meningothelioma as the predominant histological subtype of midline skull base and spinal meningioma. J Neurosurg (2006) 1.15
siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet (2008) 1.15
PTP-PEST couples membrane protrusion and tail retraction via VAV2 and p190RhoGAP. J Biol Chem (2006) 1.14
Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration. J Biol Chem (2007) 1.14
Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci (2011) 1.14
Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J Neurosci (2005) 1.12